Winmill & Co’s Elevance Health ELV Stock Holding History

Winmill & Co’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,600	Closed	-$2.81M	–	58
2026 Q1	$2.81M	Hold	9,600	–	–	0.81%	25
2025 Q4	$3.37M	Sell	9,600 -440	-4%	-$149K	0.9%	24
2025 Q3	$3.24M	Hold	10,040	–	–	0.79%	29
2025 Q2	$3.91M	Hold	10,040	–	–	1.09%	29
2025 Q1	$4.37M	Hold	10,040	–	–	1.33%	29
2024 Q4	$3.7M	Hold	10,040	–	–	1.2%	27
2024 Q3	$5.22M	Hold	10,040	–	–	1.76%	23
2024 Q2	$5.44M	Sell	10,040 -750	-7%	-$396K	1.86%	23
2024 Q1	$5.6M	Hold	10,790	–	–	1.59%	28
2023 Q4	$5.09M	Hold	10,790	–	–	1.63%	28
2023 Q3	$4.7M	Hold	10,790	–	–	1.72%	25
2023 Q2	$4.79M	Hold	10,790	–	–	1.71%	26
2023 Q1	$4.96M	Hold	10,790	–	–	1.85%	22
2022 Q4	$5.53M	Hold	10,790	–	–	2.02%	16
2022 Q3	$4.9M	Hold	10,790	–	–	1.94%	18
2022 Q2	$5.21M	Hold	10,790	–	–	1.89%	19
2022 Q1	$5.3M	Hold	10,790	–	–	1.61%	26
2021 Q4	$5M	Hold	10,790	–	–	1.44%	32
2021 Q3	$4.02M	Hold	10,790	–	–	1.29%	34
2021 Q2	$4.12M	Hold	10,790	–	–	1.48%	32
2021 Q1	$3.87M	Buy	+10,790	New	+$3.47M	1.43%	31

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Winmill & Co's ELV Position: Q2 2026 in Review

Winmill & Co sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 9,600 shares — an estimated $2.81M sold.

Winmill & Co first reported a position in ELV in Q1 2021 and held it in 21 quarters. The position peaked at $5.6M in Q1 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Winmill & Co reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
Winmill & Co sold 9,600 Elevance Health shares in Q2 2026, an estimated $2.81M.
Winmill & Co first reported a position in Elevance Health in Q1 2021 and held it in 21 quarters.
Winmill & Co's Elevance Health position peaked at $5.6M in Q1 2024.
1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Winmill & Co's 13F filing for Q2 2026, filed 13 Aug 2026.